Report Id: BBBM919
Blue Biotechnology Market Size by Product (Pharma Products, Enzymes, Biopolymers, Bulk Chemicals), By Application (Genomics, Bio-Engineering, Vaccine Development, Drug Discovery), By End-User Industry (Labs, Hospitals), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
Global blue biotechnology market is anticipated to expand at a powerful CAGR of 10.2% throughout the forecast amount of 2023-2028.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Aker BioMarine
- Marinova
- New England Biolabs
- PML Applications Ltd
- Sea Run Holdings
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
10
REPORT DESCRIPTION
Global blue biotechnology market is anticipated to expand at a powerful CAGR of 10.2% throughout the forecast amount of 2023-2028.
The combination of science and technology to develop new products used in agriculture, environment, and others are called as biotechnology. Cells and cellular components, organisms are used for the advancement of technology to improve quality of life. The consolidation of aquatic and marine organisms with technology to avail new sources of energy, develop new drugs, extract new active ingredients or just to increase food production and its safety is called as blue biotechnology. It is involved with creating of new marine technology, exploration of marine organisms to observe sea environment and health threats to human. Blue biotechnology is helpful in the diagnosis of diseases through microbial testing of microorganisms. It has wide application in the field of life science and healthcare. Blue biotechnology feels like a trending field because it's supple, adaptive, and continuously moving forward.
The applications of blue biotechnology are increasing day by day with the help of high throughput screening and genomics which is applied to tap the diversity of ocean. Tapped resources from oceans are utilized for various purposes such as treatment of AIDS virus, cosmetics, and pharmaceutical sector. The blue biotechnology market is growing rapidly and is projected to rise in upcoming years due to an increase in demand for genetically modified microorganisms. Factors such as developing aquatic renewable energy, the aquatic technology used for observation of sea atmosphere boosts the blue biotechnology market. Conserving the marine life from the pollution caused by the human race is the major restraining factor for the growing market.
The global Blue Biotechnology market is segregated on the basis of Product as Pharma Products, Enzymes, Biopolymers, and Bulk Chemicals. Based on Application the global Blue Biotechnology market is segmented in Genomics, Bio-Engineering, Vaccine Development, Drug Discovery, and Others. Based on End-User Industry the global Blue Biotechnology market is segmented in Labs and Hospitals.
The global Blue Biotechnology market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Blue Biotechnology market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Aker BioMarine, Marinova, New England Biolabs, PML Applications Ltd., Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products, GeoMarine Biotechnologies, GlycoMar, and others are among the major players in the global Blue Biotechnology market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Blue Biotechnology Market has been segmented as below:
Blue Biotechnology Market, By Product
- Pharma Products
- Enzymes
- Biopolymers
- Bulk Chemicals
Blue Biotechnology Market, By Application
- Genomics
- Bio-Engineering
- Vaccine Development
- Drug Discovery
- Others
Blue Biotechnology Market, By End-User Industry
- Labs
- Hospitals
Blue Biotechnology Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Blue Biotechnology Market, By Company
- Aker BioMarine
- Marinova
- New England Biolabs
- PML Applications Ltd.
- Sea Run Holdings
- PICES
- Donald Danforth Plant Science Center
- Shell Marine Products
- GeoMarine Biotechnologies
- GlycoMar
The report covers:
- Global Blue Biotechnology market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Blue Biotechnology market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Blue Biotechnology market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Blue Biotechnology market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Blue Biotechnology market share. Major industry players with significant revenue share include Aker BioMarine, Marinova, New England Biolabs, PML Applications Ltd., Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products, GeoMarine Biotechnologies, Glomar, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Blue Biotechnology industry trends
- Find complete analysis on the market status
- Identify the Blue Biotechnology market opportunities and growth segments
- Annalise competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Biologics Development and Manufacturing Testing market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Blue Biotechnology Market, By Product
5.1 Introduction
5.2 Pharma Products
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Enzymes
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Biopolymers
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Bulk Chemicals
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Blue Biotechnology Market, By Application
6.1 Introduction
6.2 Genomics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Bio-Engineering
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Vaccine Development
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Drug Discovery
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Others
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Blue Biotechnology Market, By End-User Industry
7.1 Introduction
7.2 Labs
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Hospitals
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Blue Biotechnology Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Blue Biotechnology, By Product
8.2.2 North America Blue Biotechnology, By Application
8.2.3 North America Blue Biotechnology, By End-User Industry
8.3 Europe
8.3.1 Europe Blue Biotechnology, By Product
8.3.2 Europe Blue Biotechnology, By Application
8.3.3 Europe Blue Biotechnology, By End-User Industry
8.4 Asia-Pacific
8.4.1 Asia-Pacific Blue Biotechnology, By Product
8.4.2 Asia-Pacific Blue Biotechnology, By Application
8.4.3 Asia-Pacific Blue Biotechnology, By End-User Industry
8.5 Rest of the World
8.5.1 Rest of the World Blue Biotechnology, By Product
8.5.2 Rest of the World Blue Biotechnology, By Application
8.5.3 Rest of the World Blue Biotechnology, By End-User Industry
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Aker BioMarine
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Marinova
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 New England Biolabs
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 PML Applications Ltd.
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Sea Run Holdings
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 PICES
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Donald Danforth Plant Science Center
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Shell Marine Products
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 GeoMarine Biotechnologies
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 GlycoMar
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Blue Biotechnology Market has been segmented as below:
Blue Biotechnology Market, By Product
- Pharma Products
- Enzymes
- Biopolymers
- Bulk Chemicals
Blue Biotechnology Market, By Application
- Genomics
- Bio-Engineering
- Vaccine Development
- Drug Discovery
- Others
Blue Biotechnology Market, By End-User Industry
- Labs
- Hospitals
Blue Biotechnology Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Blue Biotechnology Market, By Company
- Aker BioMarine
- Marinova
- New England Biolabs
- PML Applications Ltd.
- Sea Run Holdings
- PICES
- Donald Danforth Plant Science Center
- Shell Marine Products
- GeoMarine Biotechnologies
- GlycoMar
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Blue Biotechnology Market?
The market is expected to grow at a CAGR of 10% during the study period (2023-2028)
What is the segment’s covered for the Blue Biotechnology Market?
The segment included in the Blue Biotechnology Market is Product, Application, End-User Industry,region and Company.
Who are the major key vendors in the Blue Biotechnology Market?
Some key players operating in the Composite Geomembrane Market include Aker BioMarine, Marinova, New England Biolabs, PML Applications Ltd., Sea Run Holdings
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE